Sequoia China-backed biopharma company files for $100m U.S. IPO

CEBU, Philippines -- Structure Therapeutics, a clinical-stage biopharmaceutical company backed by venture capital investors, including Sequoia Capital China, has filed to raise $100 million in an initial public offering in the U.S.